Hot Prescriber Trend: GLP-1 Utilizers in Obesity Treatment Shifting to Phentermine Scripta Jun 21, 2024 2 min read Updated: Jun 24, 2024 Thanks to clinical trials that demonstrated a 12% weight-loss(1) and much buzzed about appetite-suppressing effects, the GLP-1 weight loss medications Wegovy and Zepbound, has been all over the news, and so has its high price tag
The European Medicines Agency (EMA) has similarly issued warnings to consumers
Ask yourself this: If you answered "yes" to any of those questions, chances are it's a fad diet
However, if you're looking for weight management without a diabetes diagnosis, you will probably face higher costs or need prior authorization, even for medicines that work well in that situation
When the dosage was increased, so did many of the reported adverse reactions